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The prevalence of obesity has continued to rise over the past three decades leading 
to significant increases in obesity-related medical care costs from metabolic and non- 
metabolic sequelae. It is now clear that expansion of body fat leads to an increase in 
inflammation with systemic effects on metabolism. In mouse models of diet-induced 
obesity, there is also an expansion of bone marrow adipocytes. However, the persistence 
of these changes after weight loss has not been well described. The objective of this 
study was to investigate the impact of high-fat diet (HFD) and subsequent weight loss on 
skeletal parameters in C57Bl6/J mice. Male mice were given a normal chow diet (ND) or 
60% HFD at 6 weeks of age for 12, 16, or 20 weeks. A third group of mice was put on 
HFD for 12 weeks and then on ND for 8 weeks to mimic weight loss. After these dietary 
challenges, the tibia and femur were removed and analyzed by micro computed-tomog-
raphy for bone morphology. Decalcification followed by osmium staining was used to 
assess bone marrow adiposity, and mechanical testing was performed to assess bone 
strength. After 12, 16, or 20 weeks of HFD, mice had significant weight gain relative to 
controls. Body mass returned to normal after weight loss. Marrow adipose tissue (MAT) 
volume in the tibia increased after 16 weeks of HFD and persisted in the 20-week HFD 
group. Weight loss prevented HFD-induced MAT expansion. Trabecular bone volume 
fraction, mineral content, and number were decreased after 12, 16, or 20  weeks of 
HFD, relative to ND controls, with only partial recovery after weight loss. Mechanical 
testing demonstrated decreased fracture resistance after 20  weeks of HFD. Loss of 
mechanical integrity did not recover after weight loss. Our study demonstrates that HFD 
causes long-term, persistent changes in bone quality, despite prevention of marrow 
adipose tissue accumulation, as demonstrated through changes in bone morphology 
and mechanical strength in a mouse model of diet-induced obesity and weight loss.
Keywords: obesity, bone, marrow adipose tissue, marrow fat, weight loss, leptin, high-fat diet, fracture
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inTrODUcTiOn
Over the past two decades, the prevalence of obesity has increased 
in Western countries (1, 2). In the United States, currently ~68.6% 
of adults and approximately one-third (~31.8%) of children are 
overweight or obese (3). Obesity is associated with comorbidities 
including cardiovascular and metabolic disease, autoimmune 
disorders and some cancers (1, 4–6). Recent work has suggested 
that obesity is also detrimental to bone health (7–11), with skel-
etal changes that can persist even after weight loss (10, 12).
Previously, it was assumed that obesity had a purely positive 
effect on bone mass (13–15); increased body weight provides 
mechanical stimulation, resulting in skeletal loading and bone 
accrual. However, juxtaposed to this, there is a newly recognized 
metabolic component, as the adipose tissue itself can exert a 
negative influence on bone (14). Indeed, increases in body mass 
index (BMI) have been associated with decreased bone mineral 
density (BMD) and increased fracture risk in obese adolescents 
and adults (9, 16), and in obese children (17). The effect of obesity 
on fracture risk is site specific. The presence of soft-tissue padding 
from fat may contribute to decreased fracture risk in some areas 
(e.g., hip) while unprotected sites, such as the extremities (e.g., 
humerus and ankle), have increased risk (18–20).
The cross-sectional nature of previous clinical studies can 
only identify associations between obesity and bone, thus, rodent 
models are widely utilized to explore the mechanisms underly-
ing the relationship between obesity and the skeleton. It is well 
established that high-fat feeding of mice leads to a reduction in 
cancellous bone mass (7, 12, 21, 22). This may be mediated by 
leptin-induced sympathetic tone, which has been implicated as 
strong mediator of cancellous bone loss (23–25). By compari-
son, the cortical phenotype in response to high-fat diet (HFD) 
in rodents remains unclear, with some studies indicating an 
increase (11), no change (12, 21, 22, 26) or a reduction in cortical 
bone mass (10, 27). Located within the skeleton are the bone 
marrow adipocytes; recent studies suggest that marrow adipose 
tissue (MAT) expansion occurs during high-fat feeding (28, 29). 
Whether MAT expansion and bone loss are somehow linked dur-
ing obesity is still unclear; some studies suggest that these lineages 
are correlated (29–31) while Doucette et  al. recently reported 
MAT expansion during diet-induced obesity that occurred 
independently of a bone phenotype (28).
In addition to the effects of obesity on bone, weight loss 
interventions have also been shown to have detrimental effects 
on bone metabolism, as reviewed by Brzozowska et al. (32). There 
are a range of interventions including calorie-restricted diets, 
exercise regimens, medications, and bariatric surgery (32, 33). 
Each of these interventions aim to reduce body fat and improve 
metabolic disease; the full extent to which these processes may 
alter MAT and bone mass in the context of obesity are largely 
unknown. Surgical interventions of bariatric surgery (Roux-en 
Y gastric bypass, laparoscopic adjustable gastric banding, and 
sleeve gastrectomy) have all been associated with a decline in 
bone mass despite improvements in metabolic health (32). In 
contrast to surgical weight loss, exercise has been shown to be 
quite beneficial on bone density due to increased muscle load-
ing (34–36). The most common initial intervention clinically is 
calorie restriction or “dieting.” Few studies have looked at weight 
loss in rodent models through interventions of “switching” diet. 
One study performed showed that switching back to a chow diet 
following high-fat feeding could rescue bone loss (12); however, 
the response of MAT and the interaction of MAT with bone loss 
in these models was not examined.
The objective of this study was to investigate the interaction 
between MAT and bone in the context of high-fat feeding and to 
examine the response of these tissues to dietary weight loss. We 
demonstrate that high-fat feeding leads to excess peripheral adi-
posity, MAT expansion, a reduction in bone mass and impaired 
bone strength. Weight loss led to a significant reduction in whole 
body adiposity and blocked MAT expansion; however, it failed 
to completely rescue defects in skeletal morphology and bio-
mechanics. This work begins to address the potential of adipose 
tissue within the skeleton to have an impact on bone – working, 
unlike peripheral fat, from the inside out.
MaTerials anD MeThODs
animals
Male C57Bl6/J mice (Jackson Laboratories) were given a normal 
chow diet (ND) (13.5% calories from fat; LabDiet 5LOD) or 60% 
high fat diet (HFD) (Research Diets D12492) at 6 weeks of age for 
a duration of 12, 16, or 20 weeks. A third group of mice was put 
on HFD for 12 weeks and then on ND for 8 weeks [weight loss 
(WL) group]. Animals were housed in a specific pathogen-free 
facility with a 12-h light/12-h dark cycle at ~22°C and given free 
access to food and water. All animal use was in compliance with 
the Institute of Laboratory Animal Research Guide for the Care 
and Use of Laboratory Animals and approved by the University 
Committee on Use and Care of Animals at the University of 
Michigan. The tibia was selected for our longitudinal analyses 
since it can be used to simultaneously monitor changes in rMAT 
(proximal tibia) and cMAT (distal tibia) within one sample (37). 
To compare the changes in bone within the tibia to those in the 
femur, as reported previously (12), we also analyzed the femurs 
in the 20-week groups.
Micro computed-Tomography
Tibiae were fixed in formalin for 48-h and then placed in phosphate 
buffered saline (PBS). Specimens were embedded in 1% agarose 
and placed in a 19-mm diameter tube, and the length of the bone 
was scanned using a Micro Computed-Tomography (microCT) 
system (μCT100 Scanco Medical, Bassersdorf, Switzerland). 
Scan settings were: voxel size 12 μm, medium resolution, 70 kVp, 
114 μA, 0.5 mm AL filter, and integration time 500 ms. Density 
measurements were calibrated to the manufacturer’s hydroxyapa-
tite phantom. Analysis was performed using the manufacturer’s 
evaluation software.
Femurs were removed and frozen after wrapping in PBS-soaked 
gauze and then analyzed by microCT. Femora were scanned in 
water using cone beam computed tomography (explore Locus SP, 
GE Healthcare Pre-Clinical Imaging, London, ON, Canada). Scan 
parameters included a 0.5° increment angle, four frames averaged, 
an 80 kVp and 80 μA X-ray source with a 0.508 mm AI filter to 
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reduce beam hardening artifacts, and a beam flattener around the 
specimen holder. All images were reconstructed and calibrated at 
an 18 μm isotropic voxel size to manufacturer-supplied phantom 
of air, water, and hydroxyapatite (38).
Biomechanical assessment
Following microCT scanning, femurs were loaded to failure in 
four-point bending using a servohydraulic testing machine (MTS 
858 MiniBionix, Eden Prairie, MN, USA). All specimens were 
kept hydrated in lactated ringers solution-soaked gauze until 
mechanical testing. In the same mid-diaphyseal region analyzed 
by μCT, the femur was loaded in four-point bending with the 
posterior surface oriented under tension. The distance between 
the wide, upper supports was 6.26 mm, and the span between the 
narrow, lower supports was 2.085 mm. The vertical displacement 
rate of the four-point bending apparatus in the anterior–posterior 
direction was 0.5 mm/s. Force was recorded by a 50 lb load cell 
(Sensotec) and vertical displacement by an external linear vari-
able differential transducer (LVDT, Lucas Schavitts, Hampton, 
VA, USA), both at 2000 Hz. A custom MATLAB script was used 
to analyze the raw force-displacement data and calculate all 
four-point bending parameters. Combining anterior–posterior 
bending moment of inertia data from μCT with mechanical stiff-
ness from four point bending, the estimated elastic modulus was 
calculated using standard beam theory as previously described 
(38). The modulus of elasticity was derived based on previous 
methods with “L” set at 3.57 and “a” at 0.99 (39).
Quantification of Trabecular and cortical 
Parameters with microcT
Tibia. Regions of interest (ROI) was located for both cortical and 
trabecular parameters. Analyses were performed with MicroCT 
software provided by Scanco Medical (Bassersdorf, Switzerland). 
A mid-diaphyseal cortical ROI was defined as ending at 70% of 
the distance between the growth plate and the tibia/fibula junc-
tion. A ROI spanning 360 μm (30-slices) proximal to this region 
was analyzed with standard plugins using a threshold of 280. The 
trabecular ROI was defined as starting 60 μm (5-slices) distal 
to the growth plate and ending after 600 μm total (50-slices). 
Trabecular analyses were performed with standard Scanco 
plugins with a threshold of 180.
Femur. ROI was located for both cortical and trabecular param-
eters. A diaphyseal cortical ROI spanning 18% of total femur 
length was located midway between the distal growth plate and 
third trochanter. Cortical bone was isolated with a fixed threshold 
of 2000 Hounsfield Units for all experimental groups. Parameters 
including cortical thickness, endosteal and periosteal perimeter, 
cross sectional area, marrow area, total area, anterior–posterior 
bending moment of inertia, and tissue mineral density (TMD) 
were quantified with commercially available software (MicroView 
v2.2 Advanced Bone Analysis Application, GE Healthcare Pre-
Clinical Imaging, London, ON, Canada). A trabecular ROI 10% 
of total femur length was located immediately proximal to the 
distal femoral growth plate and defined along the inner cortical 
surface with a splining algorithm. Trabecular metaphyseal bone 
was isolated with a fixed threshold of 1200 Hounsfield Units.
Quantification of Marrow adipose Tissue
Marrow adipose tissue volume within the tibia was assessed 
as described previously (37, 40). After the initial microCT 
scan, bones were decalcified in 14% EDTA solution, pH 7.4 for 
14 days at 4°C. Decalcified bones were stained with 1% osmium 
tetroxide solution in Sorensen’s phosphate buffer pH 7.4 at room 
temperature for 48  h. Osmium-stained bones were re-scanned 
using the Scanco microCT settings described above. For analysis 
of MAT within the tibia, four regions were defined as follows: (1) 
the proximal epiphysis between the proximal end of the tibia and 
the growth plate, (2) the proximal metaphysis, beginning 60 μm 
(5-slices) distal to the growth plate and ending after 600 μm total 
(50-slices), (3) the growth plate to the tibia/fibula junction (GP to 
T/F J), and the distal tibia between the tibia/fibula junction and 
the distal end of the bone. MAT volume analyses were performed 
with standard Scanco plugins with a threshold of 500.
statistics
Statistical comparisons were performed in GraphPad Prism 
(GraphPad Software, Inc., La Jolla, CA, USA). The following 
planned comparisons were performed on the graphs in Figures 1, 
2, 3 and 5: 12-week ND vs. HFD (two-tailed t-test); 16-week 
ND vs. HFD (two-tailed t-test); 20-week ND vs. HFD vs. WL 
(1-way ANOVA); 12-, 16-, 20-week ND (1-way ANOVA); 12-, 
16-, 20-week HFD (1-way ANOVA); 12-week HFD vs. 20-week 
WL (two-tailed t-test). These results were corrected for multi-
ple comparisons using the Benjamini-Hochberg procedure as 
described previously (41). For comparisons in Figures 4, 6 and 
7, a one-way ANOVA with Tukey’s correction was applied. In 
Figure 8, linear regression was applied to test the significance of 
the correlations. Raw data for the skeletal morphology, marrow 
fat quantification, and biomechanical testing is available in Data 
Sets 1–3 in Supplementary Material.
resUlTs
increases in Body Mass with high-Fat Diet 
are rescued by Weight loss
Mice were fed normal chow diet (ND) or 60% high-fat diet (HFD), 
starting at 6 weeks of age, for 12, 16, or 20 weeks. A separate group 
of mice received 12 weeks of HFD, followed by 8 weeks of ND 
to mimic weight loss (Figure 1A). Comparison of the 12-week 
HFD group to the WL group was used to determine if weight loss 
reversed changes that were already present at 12 weeks, or, rather, 
prevented further deterioration induced by continued HFD.
Increases in body mass relative to ND control were apparent 
after 12-weeks of HFD (Figure 1B). Increases in body mass rela-
tive to ND control persisted at the 16- and 20-week time points 
(Figure 1B). Over time, body mass continued to increase from 
12 to 16 weeks of HFD but stabilized between 16 and 20 weeks 
(Figure  1B). Body mass returned to normal after weight loss 
(Figure 1B). Weight gain was due, at least in part, to increases 
in liver, inguinal and gonadal white adipose tissue (WAT) mass 
after 20-weeks of HFD (Figure 1C). With weight loss, liver mass 
returned to normal; however, WAT mass was only partially 
rescued (Figure 1C).
FigUre 1 | Body and tissue mass. (a) Experiment outline. Starting at 6-weeks of age, mice were fed the indicated diets for up to 20 weeks prior to analysis. 
Seven groups of mice were analyzed as indicated by the dashed lines. ND: normal chow diet; HFD: high fat diet; WL: weight loss. (B) Body mass. N = 7-8 per 
group. (c) Tissue mass at 20 weeks. N = 4-6 per group. All graphs are mean ± SEM. “a” – significant vs. 12-week on same diet. “b” – significant vs. 16-week on 
same diet. “c” – significant vs. 12-week HFD. *p < 0.050 for the indicated comparison.
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Marrow adipose Tissue expansion after 
high-Fat Diet Feeding is inhibited  
with Weight loss
Within the tibia, MAT expansion became significant, relative to 
ND control, after 16 weeks of HFD (Figures 2A,B). With HFD, 
changes in the proximal tibial epiphysis mimicked what was 
observed between the growth plate and tibia/fibula junction, 
with a 5.5- and 4.3-fold increase at 16 weeks, relative to 12 weeks, 
respectively (Figure  2B). The distal tibia was similar, though 
there was only a 2.1-fold increase between 12 and 16 weeks of 
HFD, likely owing to the higher baseline MAT in this region 
(Figure  2B). No additional MAT accrual in any region of the 
tibia was observed between 16 and 20 weeks of HFD (Figure 2B).
In the weight loss group, the MAT in the regions of the proximal 
epiphysis and GP to T/F J was indistinguishable from that of the 
20-week ND group (Figure 2B). However, it was also similar in 
magnitude to the 12-week HFD group, suggesting that switching to 
ND was sufficient to block HFD-induced MAT expansion – rather 
than reversing MAT accrual that had already occurred.
In the distal tibia, age-associated increases in MAT were noted 
from 12- to 16-weeks of age in the ND group. Prior to correc-
tion for multiple comparisons, MAT within the distal tibia in 
the WL group was higher than chow (p = 0.019) but less than 
HFD (p = 0.050). This suggests that weight loss blunted, but did 
not entirely prevent, HFD-induced MAT expansion in the distal 
tibia at 20-weeks (Figure 2B). Raw data for these comparisons is 
available as Data Set 1 in Supplementary Material.
in the Tibia, Trabecular Bone Quality 
Decreases with high-Fat Diet and Partially 
improves with Weight loss
Consistent with previous reports (42, 43), we observed an 
age-related decrease in trabecular bone volume fraction (BVF) 
and trabecular number, with a corresponding increase in 
spacing, in the proximal tibial metaphysis of ND control mice 
(Figures 3A,C,E,G).
Relative to ND controls, mice fed a HFD had a significant 
decrease in trabecular BVF, bone mineral content (BMC), and 
number after 12-weeks of diet (Figures  3C,D,E). Structure 
model index and trabecular spacing were reciprocally increased 
(Figures 3F,G). Trabecular thickness remained unchanged (Data 
Set 1 in Supplementary Material). Loss of trabecular BVF and 
BMC with HFD, relative to control ND, persisted at the 16- and 
20-week time points (Figures 3C–G). Weight loss partially rescued 
decreases in trabecular BVF, BMC, and number (Figures 3C–E) 
and increases in spacing (Figure 3G).
Unlike loss of trabecular bone at 12-weeks, MAT volume was 
not significantly increased relative to ND control until 16- and 
20-weeks of HFD (Figure 3B). Over time, MAT increased by 3.5-
fold from 12- to 16-weeks of age in the HFD group (Figure 3B). 
FigUre 2 | region-specific changes in MaT volume with hFD and Wl. (a) 3D reconstruction of osmium tetroxide stained MAT (dark gray) overlaid on the 
tibia bone (light gray). (B) Region-specific quantification of MAT in the proximal tibial epiphysis, between the growth plate to tibia/fibula junction (GP to T/F J), and the 
distal tibia. All graphs are mean ± SEM. N = 3-6 per group for the proximal epiphysis; low N is due to accidental removal/fracture of the proximal epiphysis during 
processing. N = 6–8 for all other groups. ND, normal chow diet; HFD, high-fat diet; WL, weight loss. “a” – significant vs. 12-week on same diet. “b” – significant vs. 
16-week on same diet. “c” – significant vs. 12-week HFD. *p < 0.050 for the indicated comparison.
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No further increases were present from 16- to 20-weeks of age. 
Weight loss completely prevented HFD-induced MAT accumula-
tion from 12- to 20-weeks (Figure 3B).
in the Femur, Trabecular Bone Quality 
Decreases with high-Fat Diet and after 
Weight loss
Relative to ND control, HFD caused MAT expansion within the 
femur (Figure 4A). MAT expansion was absent in the WL group 
(Figure 4A). The absolute amount of MAT in the distal femoral 
metaphysis was ~90% less than the proximal tibia (p < 0.0001, 
t-test) (Figures 3B and 4A). The magnitude of the loss of BVF 
with HFD at 20-weeks was comparable between femur and tibia 
(50 vs. 45%) (Figure  4B; Data Sets 1 and 2 in Supplementary 
Material). There was also a significant, HFD-induced decrease 
in trabecular number and increase in trabecular spacing 
(Figures 4D,F). Trabecular thickness and tissue mineral density 
remained unchanged (Figures 4C,E). With weight loss, there were 
no statistically significant differences in trabecular morphology, 
FigUre 3 | changes in MaT and trabecular architecture at the proximal tibial metaphysis over time. (a) Representative images of trabecular architecture 
and MAT at the 20-week time point. Images of trabeculae and MAT are from the same bone for a given diet. (B–g) Quantification of MAT and trabecular parameters 
in the proximal metaphysis of the tibia. All graphs are mean ± SEM. N = 7–8 per group. ND: normal chow diet; HFD: high-fat diet; WL: weight loss. “a” – significant 
vs. 12-week on same diet. “b” – significant vs. 16-week on same diet. “c” – significant vs. 12-week HFD. *p < 0.050 for the indicated comparison.
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FigUre 4 | changes in MaT and trabecular architecture at the distal femoral metaphysis at 20-weeks. (a–F) Quantification of MAT and trabecular 
parameters in the distal metaphysis of the femur. All graphs are mean ± SEM. N = 8 per group. ND, normal chow diet; HFD, high-fat diet; WL, weight loss. 
*p < 0.050 for the indicated comparison.
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relative to HFD, in the femur (Figures 4B–F). There was a non-
significant trend toward a decrease in trabecular spacing in the 
WL group relative to HFD (Figure 4F).
changes in cortical Bone after  
high-Fat Diet and Weight loss
Within the tibia, there were no statistically significant changes 
in mid-diaphyseal cortical morphology after 12, 16, or 20 weeks 
of HFD or after weight loss (Figures  5A–F). However, slight 
differences may have been missed after statistical correction 
for multiple comparisons. For example, with standard one-way 
ANOVA at the 20-week time point only, there was a slight 
decrease in cortical thickness in the 20-week HFD group relative 
to ND control (p = 0.045) (Figure 5D). Raw data are available in 
Data Set 1 in Supplementary Material.
In the femur, 20-week HFD caused a significant decrease in 
cortical thickness relative to ND control (Figure 6D). Cortical 
tissue mineral density was also decreased with HFD (Figure 6F). 
With weight loss, cortical thickness and total mineral density 
improved relative to ND (Figures 6D,F). No differences in total 
area, marrow area, cortical area, or Iyy were noted (Figures 6A–F). 
Raw data are available in Data Set 2 in Supplementary Material.
Marrow adipose Tissue expansion 
correlates with Bone loss in the Tibia
In the control ND group, pooled over all ages (12, 16, and 20 weeks 
of diet), there was a significant inverse correlation between MAT 
volume in the proximal metaphysis and measures of trabecular 
morphology including BVF, trabecular thickness, and BMC – but 
not with trabecular number (Figures 7A–D). By contrast, in the 
HFD group, MAT volume was negatively correlated with trabecu-
lar BVF, thickness, and BMC in addition to trabecular number 
(Figures 7A–D). Cortical thickness was significantly negatively 
correlated with GP to T/F J MAT volume in the HFD group only 
(Figure 7E). Cortical TMD did not correlate with MAT volume 
in either group (Figure 7F).
high-Fat Diet causes Persistent 
Decreases in Biomechanical  
Properties of the Femur
Four-point bending was performed to assess the biomechanical 
integrity of HFD and WL femurs. The femurs from the 20-week 
HFD and WL groups broke under a reduced maximum load 
relative to ND, trending toward less total work to induce fracture 
(Figures 8A,B). This indicates that despite recovery of cortical 
FigUre 5 | changes in cortical morphology at the mid-tibial diaphysis. (a–F) Quantification of cortical parameters in the mid-diaphysis of the tibia. N = 7–8 
per group. ND: normal chow diet; HFD: high-fat diet; WL: weight loss. All graphs are mean ± SEM. “a” – significant vs. 12-week on same diet. “b” – significant vs. 
16-week on same diet. “c” – significant vs. 12-week HFD. *p < 0.050 for the indicated comparison.
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thickness and mineral density with WL (Figure  6), the bone 
quality remains impaired, leading to decreased fracture resist-
ance and poor post-yield behavior. The yield load and post-yield 
work trended toward a decrease relative to ND in the HFD and 
WL groups, respectively (p < 0.1) (Figures 8D,E). The stiffness, 
post-yield displacement, and modulus of elasticity (39) were not 
significantly different between groups (Figures 8C,F) (Data Set 3 
in Supplementary Material).
DiscUssiOn
To our knowledge, this is the first study that has measured, within 
the same bone, HFD-induced MAT expansion and changes in 
skeletal morphology. By incorporating a weight loss group, we 
were also able to inhibit MAT expansion, and thus examine the 
impact of HFD on bone quality in the absence of MAT accu-
mulation. In this study, HFD caused increases in body mass at 
12-weeks, indicating accumulation of peripheral adiposity. This 
occurred prior to increases in MAT, supporting the hypothesis 
that dysfunction of peripheral tissues (e.g., insulin resistance) 
occurs prior to HFD-induced MAT expansion.
As adipocytes and osteoblasts arise from the same mesen-
chymal progenitor cell, the notion of “fate-switching” whereby 
one lineage is favored over the other has been suggested 
(29–31). The inhibition of osteoblast differentiation may 
subsequently lead to increased adipocyte production, thus 
presenting with a situation of reduced bone mass and increased 
MAT (44). It is of note that this concept fails to capture the 
complexity of skeletal progenitors  –  some of which have the 
capacity to differentiate into osteoblasts but not adipocytes 
(45). In our study we observed the well-documented inverse 
correlation between MAT volume and bone mass/density in 
the tibia (Figure 7). However, despite this correlation, our data 
do not support the hypothesis that MAT expansion is the sole 
mediator of bone loss with HFD. Specifically, deterioration of 
trabecular architecture occurred as early as 12-weeks after HFD 
in the tibia, while changes in MAT did not become statistically 
significant until 16  weeks (Figures  2 and 3). Furthermore, 
FigUre 6 | changes in cortical morphology at the mid-femoral diaphysis. (a–F) Quantification of cortical parameters in the mid-diaphysis of the femur. N = 8 
per group. ND, normal chow diet; HFD, high-fat diet; WL, weight loss. All graphs are mean ± SEM. *p < 0.050 for the indicated comparison.
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though switching from HFD to chow at 12-weeks completely 
prevented HFD-induced MAT accumulation in the WL group 
(Figure  3B), loss of trabecular number and corresponding 
increases in trabecular spacing beyond that of controls still 
occurred (Figures  3E,G). Thus, in this context, inhibition 
of MAT expansion by weight loss was not sufficient to block 
HFD-induced decreases in trabecular bone within the tibial 
metaphysis.
There are many MAT-independent effects with the poten-
tial to regulate bone during high-fat feeding, the presence 
of which may contribute to the cancellous and cortical bone 
loss observed in this model. Increased fat mass is associated 
with increased systemic markers of oxidative stress in both 
humans and mice (4). Increased peroxide (H2O2) and reduced 
endothelial nitric oxide synthase in a genetic model of obesity 
was associated with cancellous bone loss (46). Reactive oxygen 
species have been found to promote the association of the tran-
scription factors FoxO with β-catenin, subsequently leading to 
a reduction in Wnt signaling and osteoblastic differentiation 
(47). Although the direct effects of leptin may also promote 
osteoblast proliferation and differentiation (25, 48), the central 
effects of leptin have been shown to mediate the opposite 
effects, promoting cancellous bone loss via the sympathetic 
nervous system (23, 24). Another central pathway involving 
increased neuropeptide Y (NPY) arising from leptin resistance 
during obesity is implicated in bone metabolism as mice with 
increased central NPY have concurrent obesity with bone loss 
(49) and NPY deficiency in ob/ob mice leads to improved corti-
cal bone mass (50).
Lastly, there is an increase in systemic inflammation with obe-
sity that might directly affect bone marrow osteoclasts. A major 
source of obesity-induced inflammation stems from an increase 
in bone marrow macrophages and their progenitors (51). These 
bone marrow-derived macrophages during obesity mediate an 
inflammatory environment that has been shown to stimulate 
osteoclastogenesis and reduce osteoblast development (52, 53), 
possibly due to the expansion of the common monocyte-osteo-
clast progenitor (54). Recently, Yue et al. have also demonstrated 
that leptin produced from obese adipose tissue can directly bind 
to leptin receptors on mesenchymal stem cells promoting differ-
entiation of adipocytes and inhibiting osteoblast formation (29). 
Altogether there are a number of MAT-independent variables 
involved in coordinating the relationship between diet-induced 
obesity and bone.
Though it is not the sole mediator of bone loss with HFD, our 
study does not rule out the possibility that MAT, particularly 
when present in large excess, may exert detrimental effects on 
bone. Indeed, the magnitude of cancellous bone loss in the 
FigUre 7 | MaT vs. bone over time with control or high-fat diet. (a–D) Correlation between marrow adipose tissue volume in the proximal metaphysis and 
trabecular parameters. (e,F) Correlation between marrow adipose tissue volume between the growth plate and tibia/fibula junction and cortical parameters in the 
same bone. Data grouped by diet type. ND: normal diet control for 12, 16and 20 weeks. HFD: high-fat diet for 12, 16, and 20 weeks. Linear regression. *p < 0.050 
for the indicated diet.
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tibia (Figure 3) and cortical bone loss in the femur (Figure 6) 
was significantly greater in the 20-week HFD group with MAT 
expansion than the WL group in which MAT expansion failed 
to occur. Comparisons between the femur and tibia provide 
further clues as to this relationship. Consistent with a previous 
report, 12-weeks of HFD followed by 8-weeks of normal chow 
diet (WL group) did not prevent cancellous bone loss in the dis-
tal femoral metaphysis (12). By contrast, in the same animals, 
weight loss partially prevented HFD-induced deterioration of 
trabecular BVF and BMC in the tibia (Figure 3). It is possible 
FigUre 8 | Femur biomechanical testing at 20 weeks. (a–F) Quantification of biomechanical parameters, as assessed by four-point bending. N = 12–14 per 
group. ND, normal chow diet; HFD, high-fat diet; WL, weight loss. All graphs are mean ± SEM.  *p < 0.050 for the indicated comparison.
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that this discrepancy may be explained by differences in MAT. 
After 20-weeks of HFD, the volume of MAT in the metaphysis 
of the tibia was 9.8-fold greater than in the femur. This is similar 
to previous work by Halade et  al., despite substantial differ-
ences in their model system (10% corn oil diet for 24-weeks 
in 12-month-old female mice) (44). Thus, it is possible that 
this increase in MAT contributed to additional bone loss in the 
tibia, beyond that observed in the femur, subsequently leading 
to a difference between the HFD and WL groups. However, 
given previous work, the nuances of this observation remain 
unclear (44).
Direct interactions between MAT and bone may influence 
bone loss during high fat feeding. Recently, MAT was found to 
be a significant contributor of circulating adiponectin during 
calorie restriction (55), this emphasizes the potential of MAT to 
influence not only bone but also whole body homeostasis. Direct 
adipose-bone pathways have been demonstrated to influence 
bone mass; the main two adipokines implicated are leptin (29, 
48, 56–58) and adiponectin (59–61). More locally within the bone 
microenvironment, in vitro experiments have demonstrated that 
the release of free fatty acids from adipocytes inhibited osteoblast 
differentiation and promoted apoptosis through ROS production 
(62). Interestingly, co-cultures of osteoblasts and osteoclasts with 
adipocytes suggest that in addition to reducing osteoblastogen-
esis, osteoclastogenesis may be increased with increased adipos-
ity, resulting in reduced bone mass (31).
Biomechanically, weight loss after 12-weeks of HFD was 
insufficient to rescue impaired fracture resistance. Indeed, 
the maximum load endured by the HFD and WL femurs was 
nearly identical  –  despite almost complete recovery of body 
mass and prevention of MAT expansion in the WL group. 
Comparable stiffness and modulus of elasticity in the ND, WL, 
and HFD groups indicates that the elastic properties of the 
bone were not affected. However, the failure properties were 
similarly reduced in both the HFD and WL groups, despite 
differential rescue of tissue mineral density and cortical 
thickness, implying that femur architecture fails to explain the 
impaired biomechanics. This may point to dysfunction within 
the organic properties of the bone, such as impaired cross-
linking of collagen (26), as a potential mediator of persistent 
HFD-induced fracture risk.
Our study demonstrates that HFD causes long-term, persis-
tent changes in bone quality. We started HFD at an age in which 
skeletal development is still highly active, likely contributing 
to impaired bone accrual during growth. Indeed, diet-induced 
obesity causes greater damage in growing bones (63). This 
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is an important finding given the rise of obesity in pediatric 
populations (2, 64). Furthermore, these data demonstrate that 
MAT is not necessary for HFD-induced bone loss; however, 
MAT expansion, when present, may contribute to additional 
skeletal deterioration. It is likely that changes within the bone 
 microenvironment including the adipocytes themselves are 
being altered but this was not examined in the current study 
(31, 65) and will need to be evaluated with future mechanistic 
investigations.
Given the rise in obesity across the age spectrum, this is a criti-
cal area of research and future studies are needed to determine 
the effects of weight loss (dietary or surgical) on bone density 
and to understand the mechanisms that drive changes in bone 
health. Even with the limitations a clear finding in this study is 
that there are some reversible and some permanent changes with 
HFD, followed by WL. Different regimens may be required to 
maintain bone health after WL, possibly with a focus on activity 
and diet (36).
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